Results 221 to 230 of about 7,568,653 (278)

Association Between Locomotive Syndrome and Metabolic Dysfunction‐Associated Steatotic Liver Disease in a Health Examination Cohort: A Cross‐Sectional Study

open access: yesHepatology Research, Volume 56, Issue 11, Page 1713-1722, November 2026.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with liver fat and other health problems. In this study of 7776 adults who underwent health examinations, early mobility impairment was more common in individuals with MASLD.
Shinya Yokoyama   +11 more
wiley   +1 more source

Network toxicology study and key target validation of chlorpyrifos-induced nonalcoholic fatty liver disease. [PDF]

open access: yesSci Rep
Li Y   +10 more
europepmc   +1 more source

Hepatic steatosis risk in nonobese Chinese adults with type 1 diabetes

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 11, Page 2051-2054, November 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) may be an important comorbidity in nonobese Chinese adults with type 1 diabetes (T1D). We assessed the likelihood of hepatic steatosis using the hepatic steatosis index (HSI) in 47 nonobese Chinese adults with T1D (mean age 46.9 ± 14.1 years; BMI 22.6 ± 2.5 kg/m2) and examined ...
Zehua Jin   +6 more
wiley   +1 more source

Hypocholesterolemia in liver and cardiovascular disease: Friend or foe?

open access: yesJournal of Internal Medicine, Volume 300, Issue 5, Page 572-589, November 2026.
Abstract Hypocholesterolemia is perceived as benign given its association with lower cardiovascular risk. However, genetic and epidemiological evidence indicates that persistently low levels of low‐density lipoprotein cholesterol (LDL‐C) and apolipoprotein B (ApoB) arise from distinct biological mechanisms with different hepatic implications ...
Valentina Flagiello   +3 more
wiley   +1 more source

Review: Fructose, the Sweet Culprit behind Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. [PDF]

open access: yesCurr Diabetes Rev
Otayf AY   +7 more
europepmc   +1 more source

Age‐Specific Associations of Polygenic Risk Scores With Advanced Fibrosis and Histological Activity in Biopsy‐Proven MASLD

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims The genetic susceptibility to MASLD histological severity remains incompletely defined. We assessed the associations between recently developed genome‐wide association studies–derived polygenic risk scores (PRSs) and advanced fibrosis in MASLD.
Samer Gawrieh   +9 more
wiley   +1 more source

Validation of the BARD scoring system for fibrosis detection in nonalcoholic fatty liver disease. [PDF]

open access: yesBioinformation
Anam K   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy